Therapeutic interventions for aging: The case of cellular senescenceSoto-Gamez, A. & Demaria, M. May-2017 In : Drug Discovery Today. 22, 5, p. 786-795 10 p.
Research output: Scientific - peer-review › Review article
Organismal aging is a multifactorial process characterized by the onset of degenerative conditions and cancer. One of the key drivers of aging is cellular senescence, a state of irreversible growth arrest induced by many pro-tumorigenic stresses. Senescent cells accumulate late in life and at sites of age-related pathologies, where they contribute to disease onset and progression through complex cell and non-cell autonomous effects. Here, we summarize the mechanisms by which cellular senescence can promote aging, and we offer an extensive description of current potential pharmacological interventions for senescent cells, highlighting limitations and suggesting alternatives.
|Number of pages||10|
|Journal||Drug Discovery Today|
|State||Published - May-2017|
- DNA-DAMAGE RESPONSE, NF-KAPPA-B, PLASMINOGEN-ACTIVATOR INHIBITOR-1, MESENCHYMAL STEM-CELLS, SECRETORY PHENOTYPE, CANCER-THERAPY, LIFE-SPAN, IN-VIVO, HUMAN FIBROBLASTS, NKG2D RECEPTOR